Published in Clin Neuropharmacol on July 31, 2009
The neuroimmunology of schizophrenia. Clin Psychopharmacol Neurosci (2013) 0.83
Burning pain secondary to clozapine use: a case report. BMC Psychiatry (2014) 0.75
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
Pure alexia as a disconnection syndrome: new diffusion imaging evidence for an old concept. Cortex (2008) 1.47
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull (2007) 1.38
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry (2010) 1.17
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J Neurosci (2007) 1.10
Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.05
Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res (2003) 1.04
Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations. Eur Arch Psychiatry Clin Neurosci (2009) 1.01
Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res (2004) 1.01
Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med (2005) 0.98
Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport (2004) 0.94
Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Psychopharmacology (Berl) (2012) 0.94
Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet (2007) 0.89
The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord (2011) 0.88
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex. Eur Neuropsychopharmacol (2009) 0.88
Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull (2012) 0.87
Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study. Int J Neuropsychopharmacol (2004) 0.87
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol (2011) 0.87
Specific pattern of attentional changes in impulsive individuals. Cogn Neuropsychiatry (2006) 0.86
Balneotherapy versus paroxetine in the treatment of generalized anxiety disorder. Complement Ther Med (2010) 0.86
Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J Psychiatr Res (2004) 0.86
Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport (2005) 0.86
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder. Brain (2013) 0.85
Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence. Schizophr Res (2005) 0.85
Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 0.83
Screening for Alzheimer's disease with the short cognitive evaluation battery. Dement Geriatr Cogn Disord (2003) 0.83
Confirmation of the factorial structure of temperamental autoquestionnaire TEMPS-A in non-clinical young adults and relation to current state of anxiety, depression and to schizotypal traits. J Affect Disord (2011) 0.82
Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addict Biol (2009) 0.82
Nicotine use in schizophrenia and disinhibition. Psychiatry Res (2004) 0.82
Behavioral perturbations after prenatal neurogenesis disturbance in female rat. Neurotox Res (2009) 0.82
Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia. PLoS One (2010) 0.82
Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis. Schizophr Res (2010) 0.82
Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders. Psychiatr Genet (2008) 0.81
The role of BDNF genetic polymorphisms in bipolar disorder with psychiatric comorbidities. J Affect Disord (2010) 0.81
Real world referencing and schizophrenia: are we experiencing the same reality? Neuropsychologia (2010) 0.81
Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia. BMC Genet (2006) 0.81
Association of an UCP4 (SLC25A27) haplotype with ultra-resistant schizophrenia. Pharmacogenomics (2011) 0.81
De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry (2010) 0.81
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease? Parkinsonism Relat Disord (2008) 0.81
Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients. Psychiatry Res (2008) 0.81
Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.80
Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances. Disabil Rehabil (2014) 0.80
Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia. Prog Neurobiol (2011) 0.80
Exploring and visualizing multidimensional data in translational research platforms. Brief Bioinform (2016) 0.79
Don't be Too Strict with Yourself! Rigid Negative Self-Representation in Healthy Subjects Mimics the Neurocognitive Profile of Depression for Autobiographical Memory. Front Behav Neurosci (2013) 0.79
Correlation between clinical syndromes and neuropsychological tasks in unmedicated patients with recent onset schizophrenia. Psychiatry Res (2002) 0.79
Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia. Schizophr Res (2010) 0.79
Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol. J Psychopharmacol (2010) 0.79
A step toward an objective quantification of subtle neurological signs in schizophrenia. Psychiatry Res (2012) 0.78
Impaired saccadic adaptation in schizophrenic patients with high neurological soft sign scores. Psychiatry Res (2012) 0.78
Correlates between neurological soft signs and saccadic parameters in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.78
Cannabis use and schizophrenia. Am J Psychiatry (2005) 0.78
Sensory dysfunction is correlated to cerebellar volume reduction in early schizophrenia. Schizophr Res (2007) 0.78
Attention and visual orienting in siblings, schizophrenic patients, and controls: impairment in attentional disengagement. J Clin Exp Neuropsychol (2009) 0.78
Neurological soft signs in OCD patients with early age at onset, versus patients with schizophrenia and healthy subjects. J Neuropsychiatry Clin Neurosci (2011) 0.78
Association of inflammation genes with alcohol dependence/abuse: a systematic review and a meta-analysis. Eur Addict Res (2011) 0.77
Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Psychopharmacology (Berl) (2007) 0.77
Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease. Behav Brain Funct (2013) 0.77
Variable individual sensitivity to cannabis in patients with schizophrenia. Int J Neuropsychopharmacol (2010) 0.77
Episodic memory and impairment of an early encoding process in schizophrenia. Neuropsychology (2010) 0.77
Diethylstilbestrol and risk of psychiatric disorders: a critical review and new insights. World J Biol Psychiatry (2011) 0.77
Impulsivity and sensation seeking in alcohol abusing patients with schizophrenia. Front Psychiatry (2010) 0.77
Use of bioabsorbable knotless suture anchors and associated accelerated shoulder arthropathy: report of 3 cases. Am J Sports Med (2009) 0.77
Growth hormone deficiency after mild combat-related traumatic brain injury. Pituitary (2015) 0.76
Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy. J Clin Psychopharmacol (2009) 0.76
Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression. PLoS One (2012) 0.76
Cerebellum development and schizophrenia: an association study of the human homeogene Engrailed 2. Psychiatry Res (2004) 0.76
Predictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients. J Psychiatry Neurosci (2008) 0.76
Neurological soft signs in non-psychotic patients with cannabis dependence. Addict Biol (2010) 0.76
Gender identity disorders and bipolar disorder associated with the ring Y chromosome. Am J Psychiatry (2007) 0.76
Hyperfrontality and hypoconnectivity during refreshing in schizophrenia. Psychiatry Res (2012) 0.76
Apolipoprotein E in schizophrenia: a French association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2003) 0.76
Inflexible information acquisition strategies mediate visuo-spatial reasoning in stabilized schizophrenia patients. World J Biol Psychiatry (2011) 0.76
Postnatal effect of embryonic neurogenesis disturbance on reelin level in organotypic cultures of rat hippocampus. Brain Res (2006) 0.75
[Early detection and early intervention in first episode psychosis]. Rev Prat (2013) 0.75
[Adaptation of a soft-signs scale to children with autism spectrum disorders]. Tunis Med (2009) 0.75
Behavioral disinhibition with baclofen. J Clin Psychopharmacol (2010) 0.75
Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia. Expert Opin Drug Discov (2009) 0.75
[Cannabis-induced cognitive and psychiatric disorders]. Bull Acad Natl Med (2015) 0.75
Worsening of obsessive-compulsive symptoms after treatment with aripiprazole. J Clin Psychopharmacol (2007) 0.75
[From shock therapies to new neuromodulation techniques]. Soins Psychiatr (2013) 0.75
DSM-IV diagnosis in depressed primary care patients with previous psychiatric ICD-10 bipolar disorder. J Affect Disord (2013) 0.75
[Principles of cognitive remediation in schizophrenia]. Bull Acad Natl Med (2011) 0.75
[Chromosomal integrity and schizophrenia]. Med Sci (Paris) (2009) 0.75
Comparing effects of perceptual and reflective repetition on subjective experience during later recognition memory. Conscious Cogn (2007) 0.75
[Schizophrenic disorders: current etiologic and clinical knowledge]. Bull Acad Natl Med (2005) 0.75
Ultra-resistant schizophrenia is not associated with the multidrug-resistant transporter 1 (MDR1) gene rs1045642 variant. J Clin Psychopharmacol (2011) 0.75